199 related articles for article (PubMed ID: 30793176)
21. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
[TBL] [Abstract][Full Text] [Related]
22. Subpleural honeycombing on high resolution computed tomography is risk factor for fatal pneumonitis.
Ito H; Nakayama H; Tsuboi M; Kameda Y; Yokose T; Hasegawa C; Yamada K
Ann Thorac Surg; 2011 Mar; 91(3):874-8. PubMed ID: 21353018
[TBL] [Abstract][Full Text] [Related]
23. Practice patterns in reporting interstitial lung abnormality at a tertiary academic medical center.
Escalon JG; Podolanczuk AJ; Aronson KI; Legasto AC; Gruden JF; Lynch DA; Rachid L; Rabkova Y; Steinberger S
Clin Imaging; 2023 Dec; 104():109996. PubMed ID: 37862912
[TBL] [Abstract][Full Text] [Related]
24. Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival.
Nishino M; Cardarella S; Dahlberg SE; Araki T; Lydon C; Jackman DM; Rabin MS; Hatabu H; Johnson BE
Eur J Radiol; 2015 May; 84(5):998-1004. PubMed ID: 25726730
[TBL] [Abstract][Full Text] [Related]
25. Interstitial lung abnormalities in the Queensland Lung Cancer Screening Study: prevalence and progression over 2 years of surveillance.
Mackintosh JA; Marshall HM; Slaughter R; Reddy T; Yang IA; Bowman RV; Fong KM
Intern Med J; 2019 Jul; 49(7):843-849. PubMed ID: 30350396
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis.
Yamaguchi S; Ohguri T; Ide S; Aoki T; Imada H; Yahara K; Narisada H; Korogi Y
Lung Cancer; 2013 Nov; 82(2):260-5. PubMed ID: 24054547
[TBL] [Abstract][Full Text] [Related]
27. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate.
Jin GY; Lynch D; Chawla A; Garg K; Tammemagi MC; Sahin H; Misumi S; Kwon KS
Radiology; 2013 Aug; 268(2):563-71. PubMed ID: 23513242
[TBL] [Abstract][Full Text] [Related]
28. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.
Masuda T; Hirano C; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Cancer Chemother Pharmacol; 2018 Jan; 81(1):131-139. PubMed ID: 29143072
[TBL] [Abstract][Full Text] [Related]
29. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).
Glick D; Lyen S; Kandel S; Shapera S; Le LW; Lindsay P; Wong O; Bezjak A; Brade A; Cho BCJ; Hope A; Sun A; Giuliani M
Clin Lung Cancer; 2018 Mar; 19(2):e219-e226. PubMed ID: 29066051
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil-lymphocyte ratio and a dosimetric factor for predicting symptomatic radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.
Lee YH; Choi HS; Jeong H; Kang KM; Song JH; Lee WS; Lee GW; Song HN; Kim HG; Kang MH; Rhee DY; Jeong BK
Clin Respir J; 2018 Mar; 12(3):1264-1273. PubMed ID: 28618180
[TBL] [Abstract][Full Text] [Related]
31. Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease.
Bahig H; Filion E; Vu T; Chalaoui J; Lambert L; Roberge D; Gagnon M; Fortin B; Béliveau-Nadeau D; Mathieu D; Campeau MP
Pract Radiat Oncol; 2016; 6(5):367-374. PubMed ID: 27068780
[TBL] [Abstract][Full Text] [Related]
32. Temporal and spatial dose distribution of radiation pneumonitis after concurrent radiochemotherapy in stage III non-small cell cancer patients.
Alharbi M; Janssen S; Golpon H; Bremer M; Henkenberens C
Radiat Oncol; 2017 Nov; 12(1):165. PubMed ID: 29096667
[TBL] [Abstract][Full Text] [Related]
33. [Idiopathic interstitial pneumonitis presenting with Wells grade III. Can imaging methods help predict further progression of disease?].
Fasano L; Zompatori M; Monetti N; Battista G; Pacilli AM; Scioscio V Di; Sciascia N
Radiol Med; 1999 Oct; 98(4):268-74. PubMed ID: 10615366
[TBL] [Abstract][Full Text] [Related]
34. Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality.
Putman RK; Gudmundsson G; Axelsson GT; Hida T; Honda O; Araki T; Yanagawa M; Nishino M; Miller ER; Eiriksdottir G; Gudmundsson EF; Tomiyama N; Honda H; Rosas IO; Washko GR; Cho MH; Schwartz DA; Gudnason V; Hatabu H; Hunninghake GM
Am J Respir Crit Care Med; 2019 Jul; 200(2):175-183. PubMed ID: 30673508
[No Abstract] [Full Text] [Related]
35. Interstitial lung abnormalities in patients with stage I non-small cell lung cancer are associated with shorter overall survival: the Boston lung cancer study.
Hida T; Hata A; Lu J; Valtchinov VI; Hino T; Nishino M; Honda H; Tomiyama N; Christiani DC; Hatabu H
Cancer Imaging; 2021 Jan; 21(1):14. PubMed ID: 33468255
[TBL] [Abstract][Full Text] [Related]
36. Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancer.
Shaikh T; Churilla TM; Monpara P; Scott WJ; Cohen SJ; Meyer JE
Pract Radiat Oncol; 2016; 6(6):388-394. PubMed ID: 27025161
[TBL] [Abstract][Full Text] [Related]
37. Automated CT quantification of interstitial lung abnormality in patients with resectable stage I non-small cell lung cancer: Prognostic significance.
Chung JH; Park JM; Kim DH
Thorac Cancer; 2024 Jun; 15(16):1305-1311. PubMed ID: 38682806
[TBL] [Abstract][Full Text] [Related]
38. Relationship between dose-volume parameters and pulmonary complications after neoadjuvant chemoradiotherapy followed by surgery for lung cancer.
Takahashi S; Go T; Kasai Y; Yokomise H; Shibata T
Strahlenther Onkol; 2016 Sep; 192(9):658-67. PubMed ID: 27418130
[TBL] [Abstract][Full Text] [Related]
39. Interstitial Lung Abnormality-Why Should I Care and What Should I Do About It?
Oh AS; Lynch DA
Radiol Clin North Am; 2022 Nov; 60(6):889-899. PubMed ID: 36202476
[TBL] [Abstract][Full Text] [Related]
40. Increased respiratory morbidity in individuals with interstitial lung abnormalities.
Hoyer N; Thomsen LH; Wille MMW; Wilcke T; Dirksen A; Pedersen JH; Saghir Z; Ashraf H; Shaker SB
BMC Pulm Med; 2020 Mar; 20(1):67. PubMed ID: 32188453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
